Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 18;32(9):99.
doi: 10.1007/s10856-021-06575-x.

Improved cytocompatibility and antibacterial properties of zinc-substituted brushite bone cement based on β-tricalcium phosphate

Affiliations

Improved cytocompatibility and antibacterial properties of zinc-substituted brushite bone cement based on β-tricalcium phosphate

Inna V Fadeeva et al. J Mater Sci Mater Med. .

Abstract

For bone replacement materials, osteoconductive, osteoinductive, and osteogenic properties are desired. The bacterial resistance and the need for new antibacterial strategies stand among the most challenging tasks of the modern medicine. In this work, brushite cements based on powders of Zinc (Zn) (1.4 wt%) substituted tricalcium phosphate (β-TCP) and non-substituted β-TCP were prepared and investigated. Their initial and final phase composition, time of setting, morphology, pH evolution, and compressive strength are reported. After soaking for 60 days in physiological solution, the cements transformed into a mixture of brushite and hydroxyapatite. Antibacterial activity of the cements against Enterococcus faecium, Escherichia coli, and Pseudomonas aeruginosa bacteria strains was attested. The absence of cytotoxicity of cements was proved for murine fibroblast NCTC L929 cells. Moreover, the cell viability on the β-TCP cement containing Zn2+ ions was 10% higher compared to the β-TCP cement without zinc. The developed cements are perspective for applications in orthopedics and traumatology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Diffractograms of: TCP-based cement (A) before and (B) after soaking in physiological solution and Zn-substituted TCP cement (C) before and (D) after soaking in physiological solution. Labeled peaks relate to0 (*) β-Ca3(PO4)2 (TCP) (card [09-169]), (□) CaHPO4·2H2O (DCPD) (card [72–713]), and (^) Ca10(PO4)6(OH)2 (HA) (card [72–1243])
Fig. 2
Fig. 2
FTIR spectra of: A non-substituted and Zn-substituted TCP powders, B non-substituted and Zn-substituted TCP cements, and C non-substituted and Zn-substituted TCP cements after soaking in physiological solution
Fig. 3
Fig. 3
Comparison of EPR spectra for Zn-TCP powder sample annealed at 900 °C before and after X-ray irradiation
Fig. 4
Fig. 4
Central part of the X-Ray induced EPR for Zn-TCP powder sample annealed at 900 °C after 512 scans. The calculated values of g-factors are shown
Fig. 5
Fig. 5
Cements’ morphology: A, B cement based on β-TCP; C, D cement based on Zn-β-TCP; E, F cement based on β-TCP after soaking in physiological solution; G, H cement based on Zn-β-TCP after soaking in physiological solution
Fig. 6
Fig. 6
MTT test: NCTC L929 cells’ metabolic activity during 24 h of incubation with extracts from materials: 1-β-TCP, 2-Zn-β-TCP cement (*p < 0.01). Control sample (glass slide) is 100%. The error bars correspond to average ± standard deviation
Fig. 7
Fig. 7
The inhibition of growth of: E. Coli for A Zn-TCP cement and B TCP cement; C E. faecium, and D P. aeruginosa for Zn-TCP cement (1) and TCP cement (2)

References

    1. Palangkaraya A, Yong J. Population ageing and its implications on aggregate health care demand: empirical evidence from 22 OECD countries. Int J Health Care Financ Econ. 2009;9:391–402. doi: 10.1007/s10754-009-9057-3. - DOI - PubMed
    1. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature. 2004;428:487–92. doi: 10.1038/nature02388. - DOI - PubMed
    1. Betz RR. Limitations of autograft and allograft: new synthetic solutions. Orthopedics. 2002;25:s561–70. doi: 10.3928/0147-7447-20020502-04. - DOI - PubMed
    1. Seiler JG, III, Johnson J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc. 2000;9:91–7. - PubMed
    1. Drosse I, Volkmer E, Capanna R, Biase PD, Mutschler W, Schieker M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury. 2008;39:S9–S20. doi: 10.1016/s0020-1383(08)70011-1. - DOI - PubMed

MeSH terms

LinkOut - more resources